MEDICAL FACILITIES CORP (DR.CA) Fundamental Analysis & Valuation

TSX:DR • CA58457V5036

Current stock price

16.76 CAD
+0.16 (+0.96%)
Last:

This DR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DR was profitable.
  • In the past year DR had a positive cash flow from operations.
  • Of the past 5 years DR 4 years were profitable.
  • In the past 5 years DR always reported a positive cash flow from operatings.
DR.CA Yearly Net Income VS EBIT VS OCF VS FCFDR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

  • DR has a better Return On Assets (30.18%) than 92.31% of its industry peers.
  • DR's Return On Equity of 94.43% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
  • The Return On Invested Capital of DR (15.42%) is better than 92.31% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DR is significantly above the industry average of 7.68%.
Industry RankSector Rank
ROA 30.18%
ROE 94.43%
ROIC 15.42%
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
DR.CA Yearly ROA, ROE, ROICDR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 31.60%, DR belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • DR's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 15.59%, DR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DR has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 63.75%, DR belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DR has remained more or less at the same level.
Industry RankSector Rank
OM 15.59%
PM (TTM) 31.6%
GM 63.75%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
DR.CA Yearly Profit, Operating, Gross MarginsDR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DR.CA Health Analysis

2.1 Basic Checks

  • DR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • DR has less shares outstanding than it did 1 year ago.
  • DR has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DR has an improved debt to assets ratio.
DR.CA Yearly Shares OutstandingDR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DR.CA Yearly Total Debt VS Total AssetsDR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 1.40, we must say that DR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.40, DR is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • The Debt to FCF ratio of DR is 2.05, which is a good value as it means it would take DR, 2.05 years of fcf income to pay off all of its debts.
  • DR's Debt to FCF ratio of 2.05 is amongst the best of the industry. DR outperforms 92.31% of its industry peers.
  • DR has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.02, DR is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for DR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.05
Altman-Z 1.4
ROIC/WACC1.93
WACC7.98%
DR.CA Yearly LT Debt VS Equity VS FCFDR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • DR has a Current Ratio of 1.79. This is a normal value and indicates that DR is financially healthy and should not expect problems in meeting its short term obligations.
  • DR has a Current ratio of 1.79. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
  • A Quick Ratio of 1.67 indicates that DR should not have too much problems paying its short term obligations.
  • The Quick ratio of DR (1.67) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.67
DR.CA Yearly Current Assets VS Current LiabilitesDR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. DR.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 60.81% over the past year.
  • The Revenue for DR has decreased by -41.68% in the past year. This is quite bad
  • The Revenue has been decreasing by -3.59% on average over the past years.
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%

3.2 Future

  • Based on estimates for the next years, DR will show a small growth in Earnings Per Share. The EPS will grow by 6.63% on average per year.
  • The Revenue is expected to decrease by -12.02% on average over the next years. This is quite bad
EPS Next Y49.02%
EPS Next 2Y3.89%
EPS Next 3Y4.45%
EPS Next 5Y6.63%
Revenue Next Year-20.97%
Revenue Next 2Y-16.85%
Revenue Next 3Y-15.97%
Revenue Next 5Y-12.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DR.CA Yearly Revenue VS EstimatesDR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DR.CA Yearly EPS VS EstimatesDR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

8

4. DR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.35, which indicates a very decent valuation of DR.
  • 84.62% of the companies in the same industry are more expensive than DR, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of DR to the average of the S&P500 Index (25.70), we can say DR is valued rather cheaply.
  • The Price/Forward Earnings ratio is 12.15, which indicates a correct valuation of DR.
  • Based on the Price/Forward Earnings ratio, DR is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, DR is valued a bit cheaper.
Industry RankSector Rank
PE 10.35
Fwd PE 12.15
DR.CA Price Earnings VS Forward Price EarningsDR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • DR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DR is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DR is valued cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.48
EV/EBITDA 4.73
DR.CA Per share dataDR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • DR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y3.89%
EPS Next 3Y4.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DR.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.12%, DR has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.37, DR pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, DR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of DR decreases each year by -19.91%.
  • DR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • DR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.91%
Div Incr Years1
Div Non Decr Years4
DR.CA Yearly Dividends per shareDR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DR pays out 6.72% of its income as dividend. This is a sustainable payout ratio.
DP6.72%
EPS Next 2Y3.89%
EPS Next 3Y4.45%
DR.CA Yearly Income VS Free CF VS DividendDR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
DR.CA Dividend Payout.DR.CA Dividend Payout, showing the Payout Ratio.DR.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DR.CA Fundamentals: All Metrics, Ratios and Statistics

MEDICAL FACILITIES CORP

TSX:DR (3/13/2026, 7:00:00 PM)

16.76

+0.16 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners9.84%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap297.66M
Revenue(TTM)257.36M
Net Income(TTM)81.33M
Analysts42.22
Price Target16.58 (-1.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend0.35
Dividend Growth(5Y)-19.91%
DP6.72%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.6%
Min EPS beat(2)-7.54%
Max EPS beat(2)6.33%
EPS beat(4)2
Avg EPS beat(4)3.38%
Min EPS beat(4)-24.98%
Max EPS beat(4)39.71%
EPS beat(8)3
Avg EPS beat(8)-25.78%
EPS beat(12)5
Avg EPS beat(12)32.86%
EPS beat(16)7
Avg EPS beat(16)-103.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)1.91%
Revenue beat(4)1
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-18.84%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)-3.49%
Revenue beat(12)4
Avg Revenue beat(12)-2.43%
Revenue beat(16)5
Avg Revenue beat(16)-2.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-5.41%
EPS NQ rev (3m)-5.41%
EPS NY rev (1m)19.3%
EPS NY rev (3m)11.02%
Revenue NQ rev (1m)-1.53%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 10.35
Fwd PE 12.15
P/S 0.85
P/FCF 4.48
P/OCF 4.12
P/B 2.54
P/tB N/A
EV/EBITDA 4.73
EPS(TTM)1.62
EY9.67%
EPS(NY)1.38
Fwd EY8.23%
FCF(TTM)3.74
FCFY22.33%
OCF(TTM)4.07
OCFY24.26%
SpS19.71
BVpS6.6
TBVpS-0.87
PEG (NY)0.21
PEG (5Y)N/A
Graham Number15.51
Profitability
Industry RankSector Rank
ROA 30.18%
ROE 94.43%
ROCE 18.66%
ROIC 15.42%
ROICexc 19.71%
ROICexgc 46.81%
OM 15.59%
PM (TTM) 31.6%
GM 63.75%
FCFM 18.99%
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
ROICexc(3y)21.7%
ROICexc(5y)18.79%
ROICexgc(3y)53.59%
ROICexgc(5y)43.79%
ROCE(3y)19.81%
ROCE(5y)17.76%
ROICexgc growth 3Y35.06%
ROICexgc growth 5Y23.36%
ROICexc growth 3Y18.42%
ROICexc growth 5Y13.1%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.05
Debt/EBITDA 1.54
Cap/Depr 25.03%
Cap/Sales 1.64%
Interest Coverage 7.65
Cash Conversion 93.1%
Profit Quality 60.09%
Current Ratio 1.79
Quick Ratio 1.67
Altman-Z 1.4
F-Score6
WACC7.98%
ROIC/WACC1.93
Cap/Depr(3y)47.79%
Cap/Depr(5y)40.36%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
EPS Next Y49.02%
EPS Next 2Y3.89%
EPS Next 3Y4.45%
EPS Next 5Y6.63%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
Revenue Next Year-20.97%
Revenue Next 2Y-16.85%
Revenue Next 3Y-15.97%
Revenue Next 5Y-12.02%
EBIT growth 1Y-46.1%
EBIT growth 3Y-6.86%
EBIT growth 5Y-4.85%
EBIT Next Year1.33%
EBIT Next 3Y-5.59%
EBIT Next 5Y-5.2%
FCF growth 1Y-6.31%
FCF growth 3Y4.28%
FCF growth 5Y3.38%
OCF growth 1Y-24.65%
OCF growth 3Y3.26%
OCF growth 5Y1.55%

MEDICAL FACILITIES CORP / DR.CA Fundamental Analysis FAQ

What is the fundamental rating for DR stock?

ChartMill assigns a fundamental rating of 6 / 10 to DR.CA.


Can you provide the valuation status for MEDICAL FACILITIES CORP?

ChartMill assigns a valuation rating of 8 / 10 to MEDICAL FACILITIES CORP (DR.CA). This can be considered as Undervalued.


Can you provide the profitability details for MEDICAL FACILITIES CORP?

MEDICAL FACILITIES CORP (DR.CA) has a profitability rating of 8 / 10.


What is the expected EPS growth for MEDICAL FACILITIES CORP (DR.CA) stock?

The Earnings per Share (EPS) of MEDICAL FACILITIES CORP (DR.CA) is expected to grow by 49.02% in the next year.


How sustainable is the dividend of MEDICAL FACILITIES CORP (DR.CA) stock?

The dividend rating of MEDICAL FACILITIES CORP (DR.CA) is 5 / 10 and the dividend payout ratio is 6.72%.